Bayer AG

Bayer AG

Health CarePharmaceuticals & Biotechnology
  • Price (EUR)101.96
  • Today's Change-0.78 / -0.76%
  • Shares traded2.33m
  • 1 Year change-13.34%
  • Beta1.0219
Data delayed at least 15 minutes, as of May 24 2018 16:35 BST.
More ▼

Key statistics

On Thursday, Bayer AG (BAYX.N:GER) closed at 101.96, 14.81% above the 52 week low of 88.81 set on Mar 26, 2018.
52-week range
88.81Mar 26 2018123.90Jun 19 2017
Markit short selling activity
Previous close102.74
Average volume2.24m
Shares outstanding857.95m
Free float857.95m
P/E (TTM)24.39
Market cap88.15bn EUR
EPS (TTM)4.21
Annual div (ADY)2.80
Annual div yield (ADY)2.73%
Div ex-dateMay 01 2017
Div pay-dateMay 04 2017
Next div ex-dateMay 28 2018
Next div pay-dateMay 30 2018
Data delayed at least 15 minutes, as of May 24 2018 16:35 BST.
More ▼

Board of Management


Dr. Marijn Dekkers, Chairman


Werner Baumann, Strategy and Portfolio Management


Johannes Dietsch, Finance


Michael König, Human Resources, Technology and Sustainability


Kemal Malik, Innovation

News Feed

Investor Relations Contact

Dr. Alexander Rosar
Head of Investor Relations
Bayer AG Investor RelationsBuilding W 11
D-51368 Leverkusen

Tel.: +49-214-30-81013
Fax: +49-214-30-9681013 
Email: alexander.rosar@bayer.com

© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.